vs

Side-by-side financial comparison of Ardent Health, Inc. (ARDT) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.6B, roughly 1.2× Ardent Health, Inc.). Ardent Health, Inc. runs the higher net margin — 2.8% vs 0.1%, a 2.7% gap on every dollar of revenue.

Goodlife Health Clubs is a chain of health clubs, with more than 80 locations in Australia.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

ARDT vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.2× larger
CME
$1.9B
$1.6B
ARDT
Higher net margin
ARDT
ARDT
2.7% more per $
ARDT
2.8%
0.1%
CME

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ARDT
ARDT
CME
CME
Revenue
$1.6B
$1.9B
Net Profit
$45.0M
$1.2M
Gross Margin
Operating Margin
5.8%
0.1%
Net Margin
2.8%
0.1%
Revenue YoY
14.5%
Net Profit YoY
20.7%
EPS (diluted)
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDT
ARDT
CME
CME
Q1 26
$1.9B
Q4 25
$1.6B
$1.6B
Q3 25
$1.6B
$1.5B
Q2 25
$1.6B
$1.7B
Q1 25
$1.5B
$1.6B
Q4 24
$1.5B
Q3 24
$1.4B
$1.6B
Q2 24
$1.5B
$1.5B
Net Profit
ARDT
ARDT
CME
CME
Q1 26
$1.2M
Q4 25
$45.0M
$1.2B
Q3 25
$-23.5M
$908.0M
Q2 25
$73.0M
$1.0B
Q1 25
$41.4M
$956.2M
Q4 24
$874.6M
Q3 24
$26.3M
$912.8M
Q2 24
$42.8M
$883.2M
Operating Margin
ARDT
ARDT
CME
CME
Q1 26
0.1%
Q4 25
5.8%
61.8%
Q3 25
-0.1%
63.3%
Q2 25
7.4%
66.7%
Q1 25
5.0%
67.5%
Q4 24
62.1%
Q3 24
3.9%
64.6%
Q2 24
5.6%
65.3%
Net Margin
ARDT
ARDT
CME
CME
Q1 26
0.1%
Q4 25
2.8%
71.7%
Q3 25
-1.5%
59.1%
Q2 25
4.4%
60.6%
Q1 25
2.8%
58.2%
Q4 24
57.3%
Q3 24
1.8%
57.6%
Q2 24
2.9%
57.6%
EPS (diluted)
ARDT
ARDT
CME
CME
Q1 26
Q4 25
$0.32
$3.24
Q3 25
$-0.17
$2.49
Q2 25
$0.52
$2.81
Q1 25
$0.29
$2.62
Q4 24
$2.40
Q3 24
$0.19
$2.50
Q2 24
$0.34
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDT
ARDT
CME
CME
Cash + ST InvestmentsLiquidity on hand
$709.6M
$2.4B
Total DebtLower is stronger
$1.1B
$3.4B
Stockholders' EquityBook value
$1.3B
Total Assets
$5.3B
$202.0B
Debt / EquityLower = less leverage
0.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDT
ARDT
CME
CME
Q1 26
$2.4B
Q4 25
$709.6M
$4.5B
Q3 25
$609.4M
$2.6B
Q2 25
$540.6M
$2.1B
Q1 25
$495.0M
$1.5B
Q4 24
$3.0B
Q3 24
$563.1M
$2.4B
Q2 24
$334.5M
$1.9B
Total Debt
ARDT
ARDT
CME
CME
Q1 26
$3.4B
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
ARDT
ARDT
CME
CME
Q1 26
Q4 25
$1.3B
$28.7B
Q3 25
$1.2B
$28.2B
Q2 25
$1.3B
$27.7B
Q1 25
$1.2B
$27.0B
Q4 24
$26.5B
Q3 24
$1.0B
$28.2B
Q2 24
$739.9M
$27.6B
Total Assets
ARDT
ARDT
CME
CME
Q1 26
$202.0B
Q4 25
$5.3B
$198.4B
Q3 25
$5.2B
$187.1B
Q2 25
$5.0B
$179.9B
Q1 25
$4.9B
$157.8B
Q4 24
$137.4B
Q3 24
$4.8B
$137.8B
Q2 24
$4.6B
$123.4B
Debt / Equity
ARDT
ARDT
CME
CME
Q1 26
Q4 25
0.84×
Q3 25
0.88×
Q2 25
0.87×
Q1 25
0.93×
Q4 24
Q3 24
1.08×
Q2 24
1.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDT
ARDT
CME
CME
Operating Cash FlowLast quarter
$223.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.97×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDT
ARDT
CME
CME
Q1 26
Q4 25
$223.4M
$1.1B
Q3 25
$154.4M
$968.1M
Q2 25
$117.5M
$1.1B
Q1 25
$-24.8M
$1.1B
Q4 24
$1.0B
Q3 24
$89.7M
$1.0B
Q2 24
$776.9M
Free Cash Flow
ARDT
ARDT
CME
CME
Q1 26
Q4 25
$1.1B
Q3 25
$949.7M
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$991.7M
Q3 24
$973.2M
Q2 24
$758.7M
FCF Margin
ARDT
ARDT
CME
CME
Q1 26
Q4 25
66.8%
Q3 25
61.8%
Q2 25
61.5%
Q1 25
67.1%
Q4 24
65.0%
Q3 24
61.4%
Q2 24
49.5%
Capex Intensity
ARDT
ARDT
CME
CME
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
1.1%
Q1 25
0.9%
Q4 24
1.7%
Q3 24
1.9%
Q2 24
1.2%
Cash Conversion
ARDT
ARDT
CME
CME
Q1 26
Q4 25
4.97×
0.96×
Q3 25
1.07×
Q2 25
1.61×
1.03×
Q1 25
-0.60×
1.17×
Q4 24
1.16×
Q3 24
3.41×
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons